| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 102 |
| 1 | TADALAFIL | 6 |
| 2 | FINASTERIDE | 4 |
| 3 | ATOMOXETINE HYDROCHLORIDE | 3 |
| 4 | ASPIRIN | 2 |
| 5 | ASPIRIN 325 MG | 2 |
| 6 | ASPIRIN 81 MG | 2 |
| 7 | ATORVASTATIN CALCIUM | 2 |
| 8 | FUROSEMIDE | 2 |
| 9 | ALLOPURINOL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR | 1 | 0.0013 |
| 1 | SILDENAFIL CITRATE | 102 | 0.0008 |
| 2 | ATOMOXETINE HYDROCHLORIDE | 3 | 0.0001 |
| 3 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 1 | 0.0001 |
| 4 | FINASTERIDE | 4 | 0.0001 |
| 5 | TADALAFIL | 6 | 0.0001 |
| 6 | SOFOSBUVIR | 1 | 0.0001 |
| 7 | TAMSULOSIN HYDROCHLORIDE | 1 | 0.0000 |
| 8 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 1 | 0.0000 |
| 9 | LISDEXAMFETAMINE DIMESYLATE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 1 | Phosphodiesterase 5 Inhibitor [EPC] | 6 | 0.0000 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 4 | 0.0000 |
| 3 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 5 | alpha-Adrenergic Blocker [EPC] | 1 | 0.0000 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Loop Diuretic [EPC] | 2 | 0.0000 |
| 8 | Factor Xa Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 2 | 0.0000 |